Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi, EU Medicines Agencies Flag Acquired Hemophilia Link To Clopidogrel

This article was originally published in The Pink Sheet Daily

Executive Summary

Although only 12 cases have been reported to the company, extensive use of the anti-platelet drug and shortfalls in adverse event reporting systems mean the number could rise.

You may also be interested in...

Evidence Growing That Drug Counterfeiters Are Targeting Generics In The EU

Counterfeit omeprazole has been found for the third time in Germany, suggesting that the generics sector must raise its game to combat this phenomenon.

Sanofi Set To Seek $442 Million From Apotex For Plavix Infringement

District court denies Apotex's request to stay the award of damages; Patent Office reexamination finds Plavix patent is valid.

Plavix Sales Plummet With Generic Entry

Bristol estimates that “at risk” launch of generic clopidogrel impacted U.S. pharma sales by $525 mil. to $600 mil.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts